Insider Stock Trading History of Burgess Daniel D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Burgess Daniel D since year 2005. The trader's CIK number is 1239650. At the time of this reporting, Burgess Daniel D is the Director of Cidara Therapeutics, Inc. . (stock ticker symbol CDTX). See this page for all insider trading activities at Cidara Therapeutics, Inc. .

Note that in the past BURGESS DANIEL D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Burgess Daniel D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-04-20 CDTX Cidara Therapeutics, Inc. Buy 3,000 16.00 48,000
2013-06-03 SNTS Santarus Inc Option Ex 8,000 3.00 24,000
2013-06-03 SNTS Santarus Inc Sale 8,000 21.34 170,728
2013-05-01 SNTS Santarus Inc Sale 8,000 17.88 143,048
2013-05-01 SNTS Santarus Inc Option Ex 8,000 3.00 24,000
2013-04-01 SNTS Santarus Inc Option Ex 8,000 2.09 16,720
2013-04-01 SNTS Santarus Inc Sale 8,000 17.47 139,776
2013-03-01 SNTS Santarus Inc Option Ex 8,000 1.18 9,440
2013-03-01 SNTS Santarus Inc Sale 8,000 13.37 106,952
2013-02-01 SNTS Santarus Inc Option Ex 8,000 1.18 9,440
2013-02-01 SNTS Santarus Inc Sale 8,000 13.28 106,248
2007-02-14 HEPH Hollis Eden Pharmaceuticals Inc /de/ Sale 2,250 5.50 12,375

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Burgess Daniel D (Director of Cidara Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.